WANDA ROARK: Open Payments
NPI 1134332117 · GROESBECK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 41 payments from 14 companies in 2025. Trend: 2023 $1,132 · 2024 $1,158 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $211 |
| Phathom Pharmaceuticals, Inc. | 7 | $93 |
| Amgen Inc. | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Novo Nordisk Inc | 3 | $52 |
| PFIZER INC. | 2 | $48 |
| Dexcom, Inc. | 2 | $36 |
| Lilly USA, LLC | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $26 |
Products named: VRAYLAR, VOQUEZNA, Kerendia, EVENITY, PREVNAR 20, UBRELVY, Wegovy, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
